The Journal of Organic Chemistry
Featured Article
1
(2) (64 mg, 0.146 mmol, 68%): H NMR (360 MHz, CDCl3) δ 7.79
(400 MHz, CDCl3) δ 7.68 (1H, s), 7.23 (1H, d, J = 12.8 Hz), 6.74
(1H, d of t, J = 18.2, 4.3 Hz), 6.43 (1H, s), 5.84 (1H, d, J = 12.8 Hz),
5.81 (1H, s), 4.59 (2H, d of d, J = 4.2, 1.7 Hz), 4.16 (2H, q, 3.88, J =
7.12 Hz), 3.87 (3H, s), 3.83 (3H, s), 1.29 (15H, m); 13C NMR (75
MHz, CDCl3) δ 166.5, 152.0, 151.2, 147.3, 142.7, 138.2, 120 (br.),
117.3, 116.1, 114.5, 98.10, 83.6, 70.9, 60.2, 56.6, 56.2, 25.0, 14.4; IR
(neat) 2973, 2921, 2852, 2531, 2162, 2030, 1670, 1647 cm−1; (TOF
MS APCI+, m/z) 419.2 (M + H+); HRMS (TOF MS ES+, m/z) calcd
for C22H32O7B (M + H+) 419.2241, found 419.2213.
Experimental Procedure for LC/MS Monitoring of Reagent 2
Response to Hydrogen Peroxide (Figure 3b). A hydrogen
peroxide solution (3 μL, 1.0 M in water) was added to a solution of
2 (500 μL, 2.3 mM in 1:1 MeOH−40 mM HEPES buffer, pH 7.9) and
naphthalene (0.5 mM). The mixture was agitated by vortex for ∼5 s.
An aliquot of the resulting mixture was injected into an analytical
reversed-phase HPLC coupled to a mass spectrometer, and additional
aliquots were injected at regular intervals. After injection of the sample,
an isocratic solvent gradient was run as 3:2 acetonitrile−water for 20
min.
Procedure for Monitoring the Time-Dependent UV−vis
Response of 2 to Hydrogen Peroxide (Figure 3b). A hydrogen
peroxide solution (690 μL, 0 and 3 μM in 40 mM phosphate buffer,
pH 7.0) was added to a solution of 2 (20 μL, 4 mM in MeOH) in a 1.5
mL centrifuge tube, agitated with a vortex mixer for ∼7 s, and then
transferred to a quartz cuvette. The UV−vis spectrum was then
monitored until no further changes were detected (∼10 min).
Procedure for Monitoring the Time-Dependent Fluores-
cence Response of 2 to Hydrogen Peroxide (Figure 3c). A
hydrogen peroxide solution (330 μL, 0 and 3 μM in 40 mM phosphate
buffer, pH 7.0) was added to a solution of 2 (20 μL, 4 mM in MeOH)
in a 1.5 mL centrifuge tube, agitated with a vortex mixer for ∼7 s, and
then transferred to a quartz cuvette. The fluorescence spectrum was
then monitored until no further changes were detected (∼10 min).
General Experimental for Hydrogen Peroxide Fluorescence
Emission Calibration Curve. A hydrogen peroxide solution (330
μL, 0−100 μM in 40 mM HEPES buffer, pH 7.9) was added to a
solution of 2 (20 μL, 4 mM in MeOH) in an ultramicro cuvette,
capped, and agitated with a vortex mixer for ∼7 s. After 30 min, the
fluorescence emission (I) of the mixture was measured, and the
average fluorescence of the 0 μM hydrogen peroxide sample (I0) was
subtracted (I − I0); this difference was then plotted to obtain a
calibration curve. (I = fluorescence intensity after 30 min from the
initial mixing of solutions; I0 = fluorescence intensity after 30 min from
the initial mixing of the solutions with 0 μM hydrogen peroxide.)
General Procedure for Enzyme Assays (Figure 4). To a
premixed solution of 2 (20 μL, 4 mM in MeOH), glucose oxidase
(100 μL, 15 U·mL−1 in pH 7.01 20 mM phosphate buffer and 400 mM
NaCl), and glucose-6-phosphate or lactose (100 μL, 200 mM in DI
H2O) was added a solution of alkaline phosphatase or β-D-
galactosidase (130 μL, 0−100 nM, in pH 7.01 20 mM phosphate
buffer and 400 mM NaCl) respective of enzyme substrate. This
solution was vortex mixed for ∼10 s and the fluorescence measured at
30 min and 1 h. The fluorescence emission (I) of the mixture was
measured, and the average fluorescence of the 0 μM enzyme sample
(I0) was subtracted (I − I0), this difference was plotted to obtain a
calibration curve. (I = fluorescence intensity after 30 min or 1 h from
the initial mixing of solutions; I0 = fluorescence intensity after 30 min
from the initial mixing of the solutions with 0 μM enzyme.)
(1H, s), 7.05 (1H, d, J = 12.7 Hz), 6.74 (1H, d of t, J = 18.3, 4.1 Hz),
6.41 (1H, s), 6.07 (1H, d, J = 12.7 Hz), 5.83 (1H, d, J = 18.2 Hz), 4.60
(2H, d of d, J = 3.9, 1.4 Hz), 3.88 (6H, s), 2.92 (2H, q, J = 7.4 Hz),
1.26 (15H, m); 13C NMR (75 MHz, CDCl3) δ 190.4, 153.0, 152.1,
147.6, 143.0, 135.3, 123.9, 120 (br.), 116.4, 114.5, 98.1, 84.1, 71.3,
56.9, 56.6, 25.4, 24.3, 15.4; IR (neat) 2974, 2932, 2839, 2531, 2161,
2029, 1655 cm−1; (TOF MS APCI+, m/z) 435.2 (M + H+); HRMS
(TOF MS ES+, m/z) calcd for C22H32O6BS (M + H+) 435.2013,
found 435.1994.
S-Ethyl (Diethoxyphosphinyl)ethanethioate (15). A solution
of diethylphosphonoacetic acid (14) (420 μL, 2.61 mmol, 1 equiv)
and DMAP (31 mg, 0.253 mmol, 0.097 equiv) were mixed in CH2Cl2
(9 mL) under argon and cooled to 0 °C. To this solution were added
ethanethiol (1 mL, 13.5 mmol, 5.17 equiv) and EDCI (600 mg, 3.13
mmol, 1.20 equiv). The reaction was stirred for 10 min, at which point
the argon inlet was removed, and the reaction was stirred for 8 h at 0
°C in a tightly sealed vessel. The mixture was concentrated under
reduced pressure to a clear oil and redissolved in Et2O (50 mL). The
organic layer was washed with NaHCO3 (2 × 50 mL), 0.5 M HCl (2 ×
50 mL), DI H2O (1 × 50 mL), and brine (3 × 50 mL), dried over
MgSO4, filtered, and concentrated in vacuo to yield S-ethyl
(diethoxyphosphinyl)ethanethioate (15) as a clear oil (0.216 g, 0.90
1
mmol, 34%): H NMR (360 MHz, CDCl3) δ 4.17 (4H, quin., J = 7.2
Hz), 3.21 (2H, d, JP−H = 21.3 Hz), 2.92 (2H, q, J = 7.5 Hz), 1.34 (5H,
t, J = 7.1 Hz), 1.27 (3H, t, J = 7.5 Hz). This spectral data is consistent
with data for the known compound.62
(2E)-S-Ethyl 3-(2-((2E)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxa-
borolanyl)-2-propenoxy)-4,5-dimethoxyphenyl)-
propenethioate (12). This procedure was adapted from the work of
Mandal et al.63 Cs2CO3 (29 mg, 0.135 mmol, 1.62 equiv) and 9 (29
mg, 83 μmol, 1 equiv) were dissolved in 2.5 mL of THF under argon.
To this solution was added 15 (22 mg, 0.112 mmol, 1.35 equiv) in 2.5
mL of THF. The solution was heated at 50 °C for 16 h and then
cooled to room temperature. This mixture was concentrated in vacuo,
redissolved in the Et2O (50 mL), and washed with 1 M phosphate
buffer pH 6.8 (2 × 50 mL), DI H2O (1 × 50 mL), and brine (2 × 50
mL). The organic layer was dried over MgSO4, filtered, and
concentrated to an oil that was purified by column chromatography
(30% EtOAc/hexanes). The product was dried in vacuo overnight to
give a vibrant yellow oil, (2E)-S-ethyl-3-(2-((2E)-3-(4,4,5,5-tetrameth-
yl-1,3,2-dioxaborolanyl)-2-propenoxy)-4,5-dimethoxyphenyl)-
1
propenethioate (12) (7 mg, 17 μmol, 20%): H NMR (360 MHz,
CDCl3) δ 7.95 (1H, d, J = 15.9 Hz), 6.99 (1H, s), 6.75 (1H, d of t, J =
18.3, 4.1 Hz), 6.63 (1H, d, J = 15.9 Hz), 6.43 (1H, s), 5.79 (1H, d, J =
18.2 Hz), 4.66 (2H, d, J = 2.3 Hz), 3.87 (6H, s), 2.99 (2H, q, 7.2 Hz),
1.30 (15H, m); 13C NMR (75 MHz, CDCl3) δ 190.2, 153.4, 152.4,
147.1, 143.6, 135.3, 123.1, 120.6 (br), 115.1, 110.5, 98.5, 84.8, 71.0,
56.5, 56.2, 24.9, 23.3, 15.0; IR (neat) 2975, 2932, 2543, 2163, 2030,
1649, 1593 cm−1; (TOF MS APCI+, m/z) 435.2 (M + H+); HRMS
(TOF MS ES+, m/z) calcd for C22H32O6BS (M + H+) 435.2013,
found 435.2007.
(2Z)-Ethyl 3-(2-((2E)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaboro-
lanyl)-2-propenoxy)-4,5-dimethoxyphenyl)acrylate (13). This
procedure was modified from the procedure reported by Touchard.61
18-Crown-6 ether (70 mg, 0.265 mmol, 1.91 equiv) and anhydrous
K2CO3 (75 mg, 0.543 mmol, 3.91 equiv) were dissolved in 5 mL of
THF under argon and allowed to equilibrate overnight. The cloudy
solution was cooled −40 °C, and 9 (50 mg, 0.144 mmol, 1.04 equiv)
was added in one portion. Compound 10 (33 μL, 0.139 mmol, 1
equiv) was then added, and the pale yellow solution was stirred in the
dark under argon at −40 °C for 5 h. This mixture concentrated in
vacuo in the dark, redissolved in the Et2O (50 mL), and washed with 1
M phosphate buffer pH 7.1 (2 × 50 mL), water (1 × 50 mL), and
brine (2 × 50 mL). The organic layer was dried over MgSO4, filtered,
and concentrated to an oil that was purified by column
chromatography (20% EtOAc/hexanes). The product was concen-
trated dried in vacuo overnight to a white solid, (2Z)-ethyl 3-(2-((2E)-
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-2-propenoxy)-4,5-
Procedure for Forced-Choice Ascending Concentration
Series Method for Limit of Detection by Smell Using ASTM
Protocol. Six sample sets of three mixed solutions of 2 (20 μL, 4 mM
in MeOH), glucose oxidase (100 μL, 15 U·mL−1 in pH 7.01, 20 mM
phosphate buffer and 400 mM NaCl), and glucose-6-phosphate or
lactose (100, μL, 200 mM in DI H2O) were prepared in 600 μL
microcentrifuge tubes. Out of each set, two of the samples were blanks
and had buffer (130 μL, pH 7.01 20 mM phosphate buffer and 400
mM NaCl) added. The remaining sample contained increasing
concentrations of alkaline phosphatase or β-D-galactosidase (130 μL,
0−100 nM, in pH 7.01 20 mM phosphate buffer and 400 mM NaCl).
These solutions were mixed by vortex for ∼10 s and then timed for 30
1
dimethoxyphenyl)acrylate (13) (35 mg, 83 μmol, 59%): H NMR
G
J. Org. Chem. XXXX, XXX, XXX−XXX